SNSE
New name, new vibe
Sensei Biotherapeutics is officially changing its corporate name to Faeth Therapeutics. Think of it as a biotech doing a wardrobe refresh right before a big pitch meeting: same company, different outfit.
Why investors should care
The company says its common stock is expected to begin trading on the Nasdaq Capital Market under the new ticker FTH on June 16, 2026. So if you own SNSE, don’t panic when the old ticker starts looking like yesterday’s news.
The fine print
A few extra breadcrumbs came with the announcement:
- The company also launched a new website at faeththerapeutics.com
- On June 10, 2026, stockholders approved the conversion of the company’s Series B preferred stock
That preferred-stock approval is the kind of behind-the-scenes cleanup that often shows up when a company is trying to simplify its capital structure and get ready for whatever comes next.
Big picture: this isn’t a blockbuster trial readout or a giant merger. It’s a corporate reset — but in biotech, branding changes can be a clue that management wants investors to see a cleaner story and a more focused pipeline.